vs
Side-by-side financial comparison of GLAUKOS Corp (GKOS) and RISKIFIED LTD. (RSKD). Click either name above to swap in a different company.
RISKIFIED LTD. is the larger business by last-quarter revenue ($234.0M vs $150.6M, roughly 1.6× GLAUKOS Corp). GLAUKOS Corp runs the higher net margin — 6.2% vs -13.2%, a 19.4% gap on every dollar of revenue.
Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.
Riskified is a publicly traded software company headquartered in Tel Aviv, Israel, with additional offices in New York City. The company provides software-as-a-service (SaaS) solutions focused on fraud prevention, chargeback management, and risk intelligence for e-commerce merchants.
GKOS vs RSKD — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $150.6M | $234.0M |
| Net Profit | $9.4M | $-30.8M |
| Gross Margin | 77.9% | 52.2% |
| Operating Margin | 9.0% | -19.0% |
| Net Margin | 6.2% | -13.2% |
| Revenue YoY | 41.2% | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $150.6M | — | ||
| Q4 25 | $143.1M | — | ||
| Q3 25 | $133.5M | $234.0M | ||
| Q2 25 | $124.1M | $155.1M | ||
| Q1 25 | $106.7M | $76.4M | ||
| Q4 24 | $105.5M | — | ||
| Q3 24 | $96.7M | $213.5M | ||
| Q2 24 | $95.7M | $141.7M |
| Q1 26 | $9.4M | — | ||
| Q4 25 | $-133.7M | — | ||
| Q3 25 | $-16.2M | $-30.8M | ||
| Q2 25 | $-19.7M | $-21.1M | ||
| Q1 25 | $-18.1M | $-11.6M | ||
| Q4 24 | $-33.6M | — | ||
| Q3 24 | $-21.4M | $-55.8M | ||
| Q2 24 | $-50.5M | $-34.8M |
| Q1 26 | 77.9% | — | ||
| Q4 25 | -1.1% | — | ||
| Q3 25 | 78.4% | 52.2% | ||
| Q2 25 | 78.3% | 53.6% | ||
| Q1 25 | 77.2% | 55.1% | ||
| Q4 24 | 72.9% | — | ||
| Q3 24 | 76.6% | 48.7% | ||
| Q2 24 | 76.4% | 51.4% |
| Q1 26 | 9.0% | — | ||
| Q4 25 | -97.7% | — | ||
| Q3 25 | -12.3% | -19.0% | ||
| Q2 25 | -18.3% | -19.4% | ||
| Q1 25 | -19.4% | -20.8% | ||
| Q4 24 | -27.2% | — | ||
| Q3 24 | -25.5% | -32.9% | ||
| Q2 24 | -31.3% | -31.8% |
| Q1 26 | 6.2% | — | ||
| Q4 25 | -93.4% | — | ||
| Q3 25 | -12.2% | -13.2% | ||
| Q2 25 | -15.8% | -13.6% | ||
| Q1 25 | -17.0% | -15.2% | ||
| Q4 24 | -31.8% | — | ||
| Q3 24 | -22.1% | -26.1% | ||
| Q2 24 | -52.8% | -24.6% |
| Q1 26 | — | — | ||
| Q4 25 | $-2.34 | — | ||
| Q3 25 | $-0.28 | — | ||
| Q2 25 | $-0.34 | — | ||
| Q1 25 | $-0.32 | — | ||
| Q4 24 | $-0.56 | — | ||
| Q3 24 | $-0.39 | — | ||
| Q2 24 | $-1.00 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $276.7M | $371.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $670.9M | $382.3M |
| Total Assets | $893.3M | $495.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $276.7M | — | ||
| Q4 25 | $90.8M | — | ||
| Q3 25 | $98.2M | $371.1M | ||
| Q2 25 | $100.8M | $371.1M | ||
| Q1 25 | $114.3M | $371.1M | ||
| Q4 24 | $169.6M | — | ||
| Q3 24 | $100.1M | $440.8M | ||
| Q2 24 | $68.1M | $440.8M |
| Q1 26 | $670.9M | — | ||
| Q4 25 | $656.2M | — | ||
| Q3 25 | $769.5M | $382.3M | ||
| Q2 25 | $765.1M | $382.3M | ||
| Q1 25 | $764.0M | $382.3M | ||
| Q4 24 | $766.9M | — | ||
| Q3 24 | $668.5M | $491.7M | ||
| Q2 24 | $665.2M | $491.7M |
| Q1 26 | $893.3M | — | ||
| Q4 25 | $893.5M | — | ||
| Q3 25 | $999.4M | $495.9M | ||
| Q2 25 | $987.0M | $495.9M | ||
| Q1 25 | $966.2M | $495.9M | ||
| Q4 24 | $974.8M | — | ||
| Q3 24 | $926.5M | $601.9M | ||
| Q2 24 | $919.7M | $601.9M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
